NurrOn Pharmaceuticals

NurrOn Pharmaceuticals is a developer of disease-modifying therapies for Parkinson's disease, dedicated to creating novel targeted therapies for the treatment of incurable human diseases associated with nurr1. The company is discovering and developing substances that work through mechanisms designed to alleviate symptoms of Parkinson’s disease by protecting dopaminergic neurons, helping PD patients achieve improved clinical outcomes.